We are live on ! Find out more
ANVS icon

Annovis Bio
ANVS

28 hedge funds and large institutions have $18.3M invested in Annovis Bio in 2023 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 3

58% more capital invested

Capital invested by funds: $11.6M → $18.3M (+$6.7M)

22% more funds holding

Funds holding: 23 → 28 (+5)

4.97% more ownership

Funds ownership: 9.22% → 14.19% (+5%)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

Holders
28
Holders Change
+5
Holders Change %
+21.74%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACM
AIGH Capital Management
Maryland
+$5.93M
2
WVP
Worth Venture Partners
New Jersey
+$1.48M
3
Northern Trust
Northern Trust
Illinois
+$144K
4
LCM
Lynwood Capital Management
Ontario, Canada
+$143K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$134K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$229K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$213K
3
TRCT
Tower Research Capital (TRC)
New York
-$28.9K
4
MFG
Merit Financial Group
Georgia
-$7.07K
5
Morgan Stanley
Morgan Stanley
New York
-$4.09K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
1
AIGH Capital Management
Maryland
$5.99M +$5.93M +419,070 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$3.6M +$134K +9,459 +4%
WVP
3
Worth Venture Partners
New Jersey
$1.5M +$1.48M +104,651 New
BlackRock
4
BlackRock
New York
$1.39M +$43.1K +3,047 +3%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$738K – – –
MFG
6
Merit Financial Group
Georgia
$606K -$7.07K -500 -1%
WFAG
7
Wescott Financial Advisory Group
Pennsylvania
$595K – – –
SIAP
8
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$491K +$14.1K +1,000 +3%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$488K -$1.36K -96 -0.3%
RAM
10
Redmond Asset Management
Virginia
$486K – – –
MWM
11
Modera Wealth Management
New Jersey
$436K – – –
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$361K – – –
BCM
13
Bridgeway Capital Management
Texas
$337K – – –
State Street
14
State Street
Massachusetts
$275K – – –
Koshinski Asset Management
15
Koshinski Asset Management
Illinois
$214K – – –
Northern Trust
16
Northern Trust
Illinois
$145K +$144K +10,180 New
LCM
17
Lynwood Capital Management
Ontario, Canada
$145K +$143K +10,131 New
CC
18
Cannell & Co
New York
$143K – – –
WANY
19
Wealthspire Advisors (New York)
New York
$143K – – –
Wells Fargo
20
Wells Fargo
California
$126K +$85 +6 +0.1%
Osaic Holdings
21
Osaic Holdings
Arizona
$30.1K – – –
Morgan Stanley
22
Morgan Stanley
New York
$20.2K -$4.09K -289 -17%
CAS
23
Coppell Advisory Solutions
Texas
$18.4K +$2.62K +185 New
TRCT
24
Tower Research Capital (TRC)
New York
$7.42K -$28.9K -2,042 -80%
Bank of America
25
Bank of America
North Carolina
$2.53K +$2.5K +177 New
1
2

ANVS Hedge Fund Activity: Q2 2023 in Review

28 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q2 2023, worth a combined $18.3M — up 58% from $11.6M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new ANVS positions and 3 closed out — a net gain of 5 holders — while 4 added to existing stakes and 4 trimmed.

The largest buyer was AIGH Capital Management, opening a new position worth an estimated $5.93M. The largest seller was Jane Street, exiting entirely with an estimated $229K sold.

  • 28 institutional investors held Annovis Bio (ANVS) as of Q2 2023, up from 23 in Q1 2023.
  • Funds reported $18.3M of Annovis Bio stock for Q2 2023, up 58% quarter-over-quarter.
  • 8 funds opened new Annovis Bio positions in Q2 2023 and 3 closed out, a net change of +5 holders.
  • The largest Annovis Bio buyer in Q2 2023 was AIGH Capital Management, an estimated $5.93M added.
  • The largest Annovis Bio seller in Q2 2023 was Jane Street, an estimated $229K sold.

Based on aggregated 13F filings for Q2 2023.